MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-CH-01-0000330
Essix Biosciences Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.45 Cr
▼ 93% YoY
Net loss · FY 2025
₹1.32 Cr
Net margin -38.1%
EBITDA · FY 2025
-₹36.01 Lakh
EBITDA margin -10.4%
Authorised capital
₹27.37 Cr
Registered with MCA
Paid-up capital
₹14.81 Cr
Issued & subscribed
Open charges
₹4.2 Cr
Satisfied ₹1,638.83 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
80
Provident fund records
About Essix Biosciences Limited
Data last updated:
Essix Biosciences Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 September 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74999CH1993PLC033428. Its GSTIN is 03AAACE0210F1ZQ (Punjab). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹27.37 Cr and a paid-up capital of ₹14.81 Cr. It is led by directors including Navrattan Munjal (Managing Director) and Prabhat Khurana.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO 850 Shivalik Enclave, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.45 Cr, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹1.32 Cr (net margin -38.1%) and EBITDA of -₹36.01 Lakh (EBITDA margin -10.4%). Revenue has declined at a compounded annual rate (CAGR) of 62% over three years and 45% over five years.
The company has about 80 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹4.2 Cr and satisfied charges of ₹1,638.83 Cr on record. Court records list 593 cases involving the company, including 4 filed by the company and 589 filed against it; 4 cases are pending.
Essix Biosciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0000330). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website essixbiosciences.com.
Company details
CIN U74999CH1993PLC033428
Registration Number 033428
Incorporation Date 24 September 1993
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-CH-01-0000330
CIN history
Essix Biosciences has one previous CIN (Corporate Identification Number): U74999DL1993PLC055357. The current CIN is U74999CH1993PLC033428, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999CH1993PLC033428 | Current |
| U74999DL1993PLC055357 | Previous |
Recognitions & Rankings of Essix Biosciences
Contact details
Essix Biosciences Limited's registered office is in Chandigarh, Chandigarh. Its website is essixbiosciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSCO 850 Shivalik Enclave, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Essix Biosciences Limited, buy the company report.
Comprehensive company report
Essix Biosciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Essix Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Essix Biosciences Limited, buy the company report.
Financials of Essix Biosciences Limited
FY 2024 filings availableEssix Biosciences Limited reported revenue of ₹3.45 Cr (down 93% YoY) for FY 2025.
Revenue · FY 2025
₹3.45 Cr ▼ 93%
Net loss · FY 2025
₹1.32 Cr margin -38.1%
EBITDA · FY 2025
-₹36.01 Lakh margin -10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 93%
3 years · compounded
▼ 62%
5 years · compounded
▼ 45%
EBITDA CAGR growth
1 year
▼ 100%
3 years · compounded
▼ 28%
5 years · compounded
▼ 16%
Revenue has declined at a compounded annual rate (CAGR) of 45% over five years, including a 93% fall in the latest year. EBITDA fell 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹36.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.32 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.4% | ||||
| Net Profit Margin | -38.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Essix Biosciences Limited, buy the company report.
Board of directors and KMP of Essix Biosciences Limited
Essix Biosciences Limited currently reports 5 directors and 1 key managerial person. 12 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhat Khurana Also directs: Ind Swift Laboratories Limited | Director | 21 Dec 2021 | 4 Years 10 Months | Current |
| Navrattan Munjal Also directs: Ind Swift Laboratories Limited, MJM Remedies Private Limited, Nimbua Greenfield (Punjab) Association and 1 more | Managing Director | 24 Sep 1993 | 33 Years 1 Months | Current |
| Subhash Chander Galhotra | Director | 31 Mar 2015 | 11 Years 6 Months | Current |
| Himanshu Jain | Director | 27 Aug 2008 | 18 Years 1 Months | Current |
| Rishav Mehta Also directs: Ind Swift Laboratories Limited, Vibrant Agro Industries Limited | Director | 23 Mar 2010 | 16 Years 7 Months | Current |
| Ajit Kumar | Cfo | 31 Mar 2015 | 11 Years 6 Months | Current |
Peer comparison
Essix Biosciences Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| P K Intermediates Private Limited | ₹3.56 Cr (FY 2024) | 15.0% | Surat, Gujarat, India | |||
| Vapi Spectrochem Pvt Ltd | ₹3.47 Cr (FY 2025) | 22.0% | Vapi, Gujarat, India | |||
| Essix Biosciences Limitedthis company | ₹3.45 Cr (FY 2025) | -₹1.32 Cr | -38.1% | -93.0% | 80 | Chandigarh, India |
| Sai - Tech Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2024) | -25.0% | Navi Mumbai, Maharashtra, India | |||
| Basr Fine Chemicals Private Limited | ₹3.32 Cr (FY 2025) | 190.0% | Telangana, India |
To see the full peer comparison of Essix Biosciences Limited, buy the company report.
Auditor
Essix Biosciences Limited is audited by Mittal Consul & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mittal Consul & Co. | FY 2023 | 022326N |
Shareholding
The shareholding of Essix Biosciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Essix Biosciences Limited, buy the company report.
Charges & borrowings
Open charges
₹4.2 Cr
Satisfied charges
₹1,638.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2025 | 101129533 | Others | ₹2 Cr | Open | |
| 25 Feb 2022 | 100549284 | Others | ₹20 Lakh | Open | |
| 21 Dec 2021 | 100523303 | Others | ₹1 Cr | Open | |
| 21 Dec 2021 | 100532468 | Others | ₹1 Cr | Open | |
| 31 Jul 2020 | 100363957 | Idbi Bank Limited | ₹2.3 Cr | Satisfied |
To see the full charge records of Essix Biosciences Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Essix Biosciences Limited has 593 court cases on record: 4 filed by Essix Biosciences, 589 filed against it. 4 cases are pending and 589 are disposed.
Total cases
593
Filed by the company
4
Filed against the company
589
Pending
4
Disposed
589
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 585 | 583 | 1 |
| High courts | 6 | 4 | 2 |
| Supreme Court | 2 | 2 | 1 |
Cases on record (5 of 593)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, HARYANA | Revision petition | Filed against the company by Ind Swift Laboratories Limited | Pending |
| Supreme Court | Court case (0103-Labour Matters : Contract Labour) | Filed against the company by M/S Morion Chemicals Ltd. Through Its Director 1St Floor, Sco , Sector 30 , District: Punjab ,Chandigarh , Chandigarh and 2 others | Pending |
| District court, Chandigarh | Arbitration matter | Filed against the company by M/S Ind-Swift Laboratories Limited | Disposed |
| High Court, HARYANA | Arbitration matter | Filed against the company by Pi Industries Limited Rohit Khanna and 1 other | Disposed |
| District court, Gurugram, Haryana | Arbitration matter | Filed against the company by M/S Pi Industries Limited | Disposed |
To see the full case history of Essix Biosciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Essix Biosciences Limited was last rated by Care on 13 Dec 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 13 Dec 2021 |
To see the full credit ratings and regulatory alerts of Essix Biosciences Limited, buy the company report.
MSME payment delays
Essix Biosciences Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 13 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Euro Containers | |||
| FSP Technologies | |||
| an individual supplier | |||
| Micromeg Enterprises Private Limited | |||
| Pci Pest Control Private Limited |
To see the full MSME payment records of Essix Biosciences Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Essix Biosciences has 2 subsidiary companies and 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
2
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Dashmesh Medicare Private Limited | U24230CH2005PTC028469 | |
| B M Cosmed Private Limited | U51397DL2000PTC107600 |
To see the full group structure of Essix Biosciences Limited, buy the company report.
Employees & EPFO
Essix Biosciences Limited has a workforce of 80 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
80
Active EPFO establishments
1
GST
Essix Biosciences has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAACE0210F1ZQ | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Essix Biosciences Limited, buy the company report.
Recent activity
Essix Biosciences Limited has 29 board changes on record since 1993: 17 appointments and 12 cessations. The latest: Jagvir Singh Ahluwalia ceased to be Additional Director on 29 Sep 2025.
Ceased
Jagvir Singh Ahluwalia ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101129533 was registered on 30 Jun 2025.
AGM
Essix Biosciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Essix Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge registered on 31 Jul 2020 via Charge ID 100363957 with Idbi Bank Limited was fully satisfied on 13 Feb 2024.
Charges
A charge registered on 29 Aug 2008 via Charge ID 10119108 with Idbi Bank Limited was fully satisfied on 13 Feb 2024.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100549284 was registered on 25 Feb 2022.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100523303 was registered on 21 Dec 2021.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100532468 was registered on 21 Dec 2021.
Appointed
Prabhat Khurana was appointed as Director.
Ceased
Kamal Kant ceased to be Director.
Charges
A charge registered on 04 Mar 2013 via Charge ID 10418950 with State Bank Of India was fully satisfied on 30 Nov 2021.
43 earlier events are in the company report.
Frequently asked questions
Essix Biosciences is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 September 1993 (33+ years old) and is registered under CIN U74999CH1993PLC033428.
Essix Biosciences has 6 current directors and KMP:
- Navrattan Munjal - Managing Director
- Prabhat Khurana - Director
- Subhash Chander Galhotra - Director
- Himanshu Jain - Director
- Rishav Mehta - Director
- Ajit Kumar - Cfo
The latest financial statements of Essix Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Essix Biosciences is 03AAACE0210F1ZQ, registered in Punjab. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Essix Biosciences is U74999CH1993PLC033428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Essix Biosciences has 593 court cases on record: 4 filed by the company and 589 filed against it. 4 are pending. Most are in the district courts.
Essix Biosciences was incorporated on 24 September 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Essix Biosciences by revenue are P K Intermediates Private Limited, Vapi Spectrochem Pvt Ltd, Sai - Tech Pharmaceuticals Private Limited, Basr Fine Chemicals Private Limited, all in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagvir Singh Ahluwalia ceased to be Additional Director on 29 Sep 2025. Prabhat Khurana was appointed as Director on 21 Dec 2021. Kamal Kant ceased to be Director on 14 Dec 2021. Essix Biosciences has 29 board changes on record in total.
Yes, Essix Biosciences is registered as a medium enterprise under Udyam registration (number: UDYAM-CH-01-0000330).
Essix Biosciences has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 13 overdue payments to 10 micro and small suppliers. The latest return was filed on 30 May 2019.
Essix Biosciences can be reached through the website essixbiosciences.com. Its registered office is in Chandigarh, India.